Connection

Peter Verhamme to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Dose-Response Relationship, Drug.
Peter Verhamme
Connection Strength
0.171
Dose-Response Relationship, Drug
  1. Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation. Eur J Heart Fail. 2019 01; 21(1):129-131.
    View in: PubMed
    Score: 0.095
  2. Thrombolytic efficacy of recombinant human microplasmin in a canine model of copper coil-induced coronary artery thrombosis. J Thromb Thrombolysis. 2010 Jul; 30(1):46-54.
    View in: PubMed
    Score: 0.053
  3. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care. Eur J Anaesthesiol. 2018 Feb; 35(2):142-146.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.